CORVITA 150- iron, folic acid, ascorbic acid, pyridoxine hydrochloride, cyanocobalamin and citrate tablet

Země: Spojené státy

Jazyk: angličtina

Zdroj: NLM (National Library of Medicine)

Aktivní složka:

Iron (UNII: E1UOL152H7) (Iron - UNII:E1UOL152H7), Folic Acid (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8), ascorbic acid (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R), pyridoxine Hydrochloride (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z), Cyanocobalamin (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204), ZINC (UNII: J41CSQ7QDS) (ZINC - UNII:J41CSQ7QDS)

Dostupné s:

Trigen Laboratories, LLC

INN (Mezinárodní Name):

Iron

Složení:

Iron 150 mg

Podání:

ORAL

Terapeutické indikace:

CORVITA™ 150 should not be used by patients with a known hypersensitivity to any of the listed ingredients. All iron compounds are contraindicated in patients with hemochromatosis, hemosiderosis, or hemolytic anemias. 

Přehled produktů:

CORVITA™ 150 tablets are supplied in unit dose packs of 100 (10 blister cards of 10 tablets each). PRODUCT CODE 13811-066-10

Stav Autorizace:

Dietary Supplement

Charakteristika produktu

CORVITA 150- IRON, FOLIC ACID, ASCORBIC ACID, PYRIDOXINE
HYDROCHLORIDE,
CYANOCOBALAMIN AND CITRATE TABLET
TRIGEN LABORATORIES, LLC
----------
CORVITA
150 TABLETS
SUPPLEMENT FACTS
OTHER INGREDIENTS: Microcrystalline Cellulose, Pregelatinized Starch,
Red Color Coating
(Polyvinyl Alcohol, Polyethylene Glycol, FD&C Red #40 Lake, Talc,
Titanium Dioxide),
Croscarmellose Sodium, Magnesium Stearate, Stearic Acid
GLUTEN-, LACTOSE- AND SUGAR-FREE
CORVITA™ 150 is a prescription multivitamin/multimineral supplement
used to improve
the nutritional status of patients with iron deficiency
CONTRAINDICATIONS
TM
CORVITA™ 150 should not be used by patients with a known
hypersensitivity to any of
the listed ingredients. All iron compounds are contraindicated in
patients with
hemochromatosis, hemosiderosis, or hemolytic anemias. WARNING: ACCIDENTAL OVERDOSE OF IRON-CONTAINING
PRODUCTS IS A LEADING CAUSE OF FATAL POISONING IN
CHILDREN UNDER 6. KEEP THIS PRODUCT OUT OF
REACH OF CHILDREN. IN CASE OF ACCIDENTAL
OVERDOSE, CALL A DOCTOR OR POISON CONTROL CENTER
IMMEDIATELY.
PRECAUTIONS
GENERAL: Do not exceed recommended dose. The type of anemia and the
underlying
cause or causes should be determined before starting therapy with
CORVITA™150.
Since the anemia may be a result of a systemic disturbance, such as
recurrent blood
loss, the underlying cause or causes should be corrected, if possible.
FOLIC ACID: Folic acid alone is an improper therapy in the treatment
of pernicious anemia
and other megaloblastic anemias where vitamin B12 is deficient. Folic
acid in doses
above 0.1 mg daily may obscure pernicious anemia in that hematologic
remission can
occur while neurologic manifestations remain progressive. Allergic
sensitization has been
reported following both oral and parenteral administration of folic
acid.
The patient’s medical conditions and consumption of other drugs,
herbs, and/or
supplements should be considered.
PEDIATRIC USE: Safety and effectiveness in pediatric populations have
not been
established.
GERIATRIC USE: Safety and